PhD, Industrial Engineering and Management Sciences
MS, Industrial Engineering and Management Sciences
Northwestern University, Evanston, IL
BS, Systems Science and Engineering
Washington University in St. Louis, St Louis, MO
BS, Engineering Mathematics
Elon University, Elon, NC
Ashley Davis, PhD, is a Senior Director of Health Economics at RTI-HS. Dr. Davis uses analytical methodologies to evaluate the clinical and economic value of upcoming pharmaceutical products and changes to health care policies. She has developed cost effectiveness, cost-utility, and cost-consequence models; budget-impact models; infectious disease dynamic transmission models; and resource allocation models. She has broad experience with a wide variety of mathematical modeling techniques, including Markov and stochastic models, simulation, statistical analysis, linear and nonlinear programming, and robust optimization. Dr. Davis has extensive experience programming models and user-friendly interfaces using Visual Basic for Applications in Excel and is proficient with other software packages, including MATLAB, Octave, R, C++, Java, and SAS. Dr. Davis has developed models and analyses in the areas of HIV, influenza, respiratory syncytial virus, Ebola virus disease, hepatitis C, coronary or peripheral artery disease, cystic fibrosis, herpes zoster, pneumococcal disease, severe asthma, chronic obstructive pulmonary disease, eosinophilic esophagitis, spinal surgery, Cytomegalovirus, and organ transplantation.
Her research has been presented at various professional conferences and published in several peer-reviewed journals, including Pharmacoeconomics, PLoS One, HIV Medicine, HIV Clinical Trials, Medical Decision Making, Vaccine, Value in Health, Transplantation, Clinical Journal of the American Society of Nephrology, Institute for Operations Research and the Management Sciences (INFORMS), the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and the American Transplant Congress.